Drugs / Zucapsaicin
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT02116244 | May 2014 → Sep 2015 | dry eye syndrome | Winston Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT00845923 | Mar → Sep 2009 | postherpetic neuralgia | Winston Laboratories | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT00077935 | Nov 2003 → Jul 2005 | osteoarthritis, knee | Winston Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT00033839 | Jan 2002 → Jul 2003 | cluster headache syndrome | Winston Laboratories | Completed | No outcome recorded |
| Comparator or background therapy6 trials | ||||||
| Phase 1 | NCT00802217 Comparator | Nov 2008 → Jun 2009 | — | Winston Laboratories | Terminated | No outcome recorded |
| Phase 1 | NCT00758433 Comparator | Sep → Dec 2008 | — | Winston Laboratories | Completed | No outcome recorded |
| Phase 2 | NCT01886313 Comparator | Mar 2014 → Mar 2015 | postherpetic neuralgia | Winston Laboratories | Terminated | No outcome recorded |
| Phase 3 | NCT01341548 Comparator | Nov 2023 → Nov 2025 | cluster headache syndrome | Winston Laboratories | Unknown | No outcome recorded |
| Phase 3 | NCT00069082 Comparator | Aug 2003 → Jan 2004 | cluster headache syndrome | Winston Laboratories | Completed | No outcome recorded |
| Phase 3 | NCT00995306 Comparator | Jun 2003 → Apr 2004 | osteoarthritis, knee | Winston Laboratories | Completed | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zucapsaicin | “A DOUBLE BLIND, RANDOMIZED, VEHICLE-CONTROLLED, PARALLEL-GROUP EVALUATION OF CIVAMIDE (ZUCAPSAICIN) 0.01% AND VEHICLE NASAL SPRAYS IN THE TREATMENT OF POSTHERPETIC NEURALGIA OF...” NCT01886313 ↗3“A Phase III, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Evaluation of Civamide (Zucapsaicin) Nasal Solution in the Treatment of Episodic Cluster Headache” NCT00069082 ↗ “Civamide (Zucapsaicin)” NCT00033839 ↗ “Drug: Zucapsaicin” NCT00758433 ↗ |
| Known as | Cis-capsaicin | ChEMBL registry synonym — accepted as the source's own label CHEMBL313971 ↗ |
| Known as | Civamide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995306 ↗ |
| Known as | Zucapsaicina | ChEMBL registry synonym — accepted as the source's own label CHEMBL313971 ↗ |
| Known as | Zucapsaicine | ChEMBL registry synonym — accepted as the source's own label CHEMBL313971 ↗ |
| Action | Activate | “Vanilloid receptor agonist” CHEMBL313971 ↗ |
| Modality | Small molecule | — CHEMBL313971 ↗ |
| Route | Intranasal | “Intranasal Civamide (Zucapsaicin)” NCT00033839 ↗ |
| Target | TRPV1 | “Vanilloid receptor agonist” CHEMBL313971 ↗ |